Medicines for human use
> Important notifications – Medicines for human use
> Legislation – Medicines for human use
> Forms and tariffs – Medicines for human use
> Medicinal product authorisation
> Parallel import authorisation
> Health technologies assessment
> Clinical trials
> Last resort treatments
> Pharmacovigilance
> Report an adverse reaction
> Direct healthcare professionals communications
> Submit a medicinal product quality complaint
> Inform on medicinal product shortage
> Medicinal products under additional monitoring
> Pharmaceutical inspection
> Advertising
> Readability
> Standard terms
> Intra-Community deliveries notifications
> Drug discontinuity notifications
> Sponsorships – Medicinal products for human use
> Index of medicinal products for human use
Agency
Medical Devices
> Important notifications – Medical Devices
> Legislation – Medical Devices
> Forms and fees – Medical Devices
> European regulations on medical devices
> CE marking
> Definitions and classification of medical devices
> Registration of medical devices into the national database
> Grant of customs notice
> Grant of donation notice
> Grant of out-of-scope notice
> Vigilance
> Market surveillance
> In-use surveillance
> Clinical investigation
> Notified bodies
> Operation notice
> Record of EU/EEA service providers into the database
> Grant of notice for use
> Grant of periodic check bulletin
> Report an incident
> Sponsorships – Medical Devices
Index of medicinal products for human use
National Database for Medical Devices
SPECIAL SECTIONS
Press releases
National Agency for Medicines and Medical Devices
Important notifications
Important notification
10.05.2019 To the attention of interested persons The NAMMD would like to inform you about the 6th Romanian Pharmacovigilance Workshop [...]
Important notification
06.03.2019 To the attention of Marketing Authorisation Holders (MAHs) concerned The National Agency for Medicines and Medical Devices (NAMMD) hereby [...]
Important notification
22.10.2018 To MAH attention Given the need to reduce Brexit impact on medicine availability, please submit an updated status of [...]
IN SUPPORT OF PATIENTS
Informations for the pacients
Drug discontinuity notifications
Medicinal products under additional monitoring
MEDIA
